Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	125-135
Cyfnodolyn	Nephron Clinical Practice
Cyfrol	106
Rhif cyhoeddi	3
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1159/000103000
Statws	Cyhoeddwyd - 1 Gorff 2007

Mynediad at Ddogfen

@article{670316ba457b4804a9b41a2f528f0005,

title = "Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.",

keywords = "UROLOGY \& NEPHROLOGY",

author = "J.H. Macdonald and S.M. Marcora and M.M. Jibani and M.J. Kumwenda and W. Ahmed and A.B. Lemmey",

year = "2007",

month = jul,

day = "1",

doi = "10.1159/000103000",

language = "English",

volume = "106",

pages = "125--135",

journal = "Nephron Clinical Practice",

issn = "1660-2110",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.

AU - Macdonald, J.H.

AU - Marcora, S.M.

AU - Jibani, M.M.

AU - Kumwenda, M.J.

AU - Ahmed, W.

AU - Lemmey, A.B.

PY - 2007/7/1

Y1 - 2007/7/1

KW - UROLOGY & NEPHROLOGY

U2 - 10.1159/000103000

DO - 10.1159/000103000

M3 - Article

SN - 1660-2110

VL - 106

SP - 125

EP - 135

JO - Nephron Clinical Practice

JF - Nephron Clinical Practice

IS - 3

ER -